Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
FSGS/Nephrotic Syndrome Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 25 | 56 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
24 Genetics 24Genetics SL Spain | 7 | 1 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
GPC3 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 2 | 1 |
|
Centogene US, LLC - The Rare Disease Company United States | 243 | 238 |
|
Centogene US, LLC - The Rare Disease Company United States | 289 | 275 |
|
Centogene US, LLC - The Rare Disease Company United States | 740 | 728 |
|
Centogene US, LLC - The Rare Disease Company United States | 829 | 848 |
|
Centogene US, LLC - The Rare Disease Company United States | 669 | 688 |
|
Centogene US, LLC - The Rare Disease Company United States | 498 | 498 |
|
Centogene US, LLC - The Rare Disease Company United States | 499 | 499 |
|
Centogene US, LLC - The Rare Disease Company United States | 248 | 262 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
Centogene US, LLC - The Rare Disease Company United States | 734 | 744 |
|
Centogene US, LLC - The Rare Disease Company United States | 777 | 770 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.